Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Alternatives International (NAII) Operating Leases (2019 - 2025)

Natural Alternatives International's Operating Leases history spans 7 years, with the latest figure at $44.8 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 1.88% year-over-year to $44.8 million; the TTM value through Dec 2025 reached $44.8 million, down 1.88%, while the annual FY2025 figure was $46.0 million, 1.07% down from the prior year.
  • Operating Leases for Q4 2025 was $44.8 million at Natural Alternatives International, down from $45.3 million in the prior quarter.
  • Across five years, Operating Leases topped out at $46.9 million in Q3 2024 and bottomed at $14.6 million in Q1 2022.
  • The 5-year median for Operating Leases is $33.1 million (2022), against an average of $32.1 million.
  • The largest annual shift saw Operating Leases dropped 15.62% in 2021 before it soared 145.02% in 2024.
  • A 5-year view of Operating Leases shows it stood at $15.2 million in 2021, then soared by 40.49% to $21.3 million in 2022, then soared by 119.41% to $46.7 million in 2023, then fell by 2.23% to $45.7 million in 2024, then dropped by 1.88% to $44.8 million in 2025.
  • Per Business Quant, the three most recent readings for NAII's Operating Leases are $44.8 million (Q4 2025), $45.3 million (Q3 2025), and $46.0 million (Q2 2025).